AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2011

Sep 15, 2011

34301_dirs_2011-09-15_53a0f8da-6318-46cd-98af-a38a76b19850.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-09-14

Reporting Person: Dean Lloyd H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-09-14	Common Stock	P	1000	$3.13	Acquired	10000	Indirect
2011-09-14	Common Stock	P	2000	$3.14	Acquired	12000	Indirect
2011-09-14	Common Stock	P	2000	$3.15	Acquired	14000	Indirect
2011-09-14	Common Stock	P	1000	$3.18	Acquired	15000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Restricted Stock	21000	Direct

Footnotes

F1: These shares are owned by Lloyd H. Dean,TTE and Suzanne R. Dean, TTE, U/A DTD 8/13/2002, the Dean Family Trust.

F2: The restricted stock vests fifty percent (50%) on November 1, 2011 and fifty percent (50%) on November 1, 2012, subject to Mr. Dean's continued service to the Company.